Our portfolio companies develop breakthrough products that advance the standard of care for surgical patients. With our capital efficient approach, our portfolio companies establish clear reimbursement strategies, regulatory compliance, strong intellectual property portfolios and compelling market strategies that make for ideal acquisition candidates for medical device companies with established sales organizations
May 1, 2016
clients